Connecting biopharmas with the right preclinical cancer models and CRO partners


Posted by Repositive, October 2018

Repositive launches Personal Shopper Service to connect researchers with difficult-to-source translational cancer models

Personal Shopper Schematic

Submit your Personal Shopper Request here!

Repositive's Personal Shopper Service Launches

Starting October 1st and continuing throughout Q4 2018, we’re offering commercial scientists working in translational oncology the opportunity to take advantage of the confidential Repositive Cancer Models Personal Shopper Service to help track down the best tumour models for their next study, and as a special introductory offer, we are offering this service for free – only requesting customer testimonials.

Whether you're looking for a specific PDX model or cancer cell line or are after syngeneic mice or 3D organoids, we’ve slashed search times from two months to a week for clients and put companies who didn’t know each other existed in touch, all as part of our aim of enhancing and accelerating oncology research. And now, we want to help even more biopharmas find the best cancer models to suit their needs, which is why we’re making the Personal Shopper Service free to use until 31 December 2018.

How it works

  1. You let us know you’re searching for a translational model in our simple form above. All requests are treated in the strictest confidence
  2. The Repositive Team get in touch to sign a non-disclosure agreement, find out more about the request, and discuss timelines for the request
  3. The Repositive Team will search the 1000s of models in the inventory of our partner network for a specific model that suits your needs, or identify companies that has the capability and services to develop one
  4. You’ll receive a list of suggested company profiles based on their fit for your request, you choose which one you want to contact, and we’ll make the introductions

Connecting the Translational Oncology Community

Repositive’s CEO and Founder, Fiona Nielsen, said: “We look forward to providing crucial support and solutions for everyone involved in finding life-changing and life-saving treatments for cancer. As well as benefitting the researchers and CROs who we will be connecting, the Personal Shopper Service will support the acceleration of our Cancer Models product’s development, too. As we build its capacity to find solutions for researchers from across the globe we will increase connections within the translational oncology community and firmly establish our position as the leading Cancer Models marketplace.

“The Cancer Models product is poised to become by 2019 the world’s largest marketplace and community for translational cancer models, as we expand it beyond PDX to include CDX and syngeneic models, humanised mice, 3D ex vivo systems and other hosts and services. By connecting organisations and finding suitable pre-clinical models, drug development projects are prioritised, ultimately accelerating the development of cancer therapies for patients. The Personal Shopper Service offers a truly goal oriented, win-win situation for Repositive, researchers and CROs.”

Interested in Participating?

Researchers interested in accessing the personal shopper service should complete an enquiry form via the link above, describing the required model characteristics or CRO services. There’s no obligation to contract with the connected CRO or sign up to the Repositive platform to use this service, and all requests are confidential.

You're also very welcome to join our events for specialists in pre-clinical oncology and cancer models and tune into our upcoming webinars (sign up here for our mailing list to be notified of events and webinars).

If you have any questions related to our Personal Shopper Service, please reach out to

Click here for further information about the Cancer Models community